Orchard Therapeutics PLC (NASDAQ:ORTX)
| 7.28 Delayed Data As of 3:59pm ET |  -0.12 / -1.62%Today’s Change | 3.76 Today|||52-Week Range 13.00 | +68.52% Year-to-Date |
Latest ORTX News | Press Releases
No recent news for Orchard Therapeutics PLC.
Today’s Trading
| Previous close | 7.40 |
| Today’s open | 7.17 |
| Day’s range | 7.28 - 7.69 |
| Volume | 65,131 |
| Average volume (3 months) | 1,746,973 |
| Market cap | $681.3M |
Data as of 3:59pm ET, 03/02/2021
Growth & Valuation
| Earnings growth (last year) | +82.75% |
| Earnings growth (this year) | +16.01% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +21.76% |
| P/E ratio | NM |
| Price/Sales | 508.07 |
| Price/Book | 2.26 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| KDNYChinook Therapeutics... | +0.15 | +0.87% |
| ICPTIntercept Pharmaceut... | -0.04 | -0.18% |
| ALBOAlbireo Pharma Inc | -1.44 | -3.87% |
| ODTOdonate Therapeutics... | -0.22 | -1.14% |
Data as of 4:00pm ET, 03/02/2021
Financials
| Next reporting date | June 1, 2021 |
| EPS forecast (this quarter) | -$0.34 |
| Annual revenue (last year) | $2.5M |
| Annual profit (last year) | -$164.1M |
| Net profit margin | -6,503.06% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters London, Greater London |
Forecasts
